1887

Journal of General Virology header logo

Volume 96, Issue 12

OX40 and 4-1BB downregulate Kaposi's sarcoma-associated herpesvirus replication in lymphatic endothelial cells, but 4-1BB and not OX40 inhibits viral replication in B-cells Free

Abstract

Kaposi's sarcoma-associated herpesvirus (KSHV) belongs to the human gammaherpesvirus subfamily and is associated with malignancies of endothelial origin (Kaposi's sarcoma, KS) and B-cell origin [primary effusion lymphoma (PEL) and multicentric Castleman's disease (MCD)]. Viral lytic replication is known to be required for KS and MCD. As KSHV-related tumours mostly develop in human subjects when the immune system is compromised by immunosuppressive regimen, human immunodeficiency virus infection or some genetic deficiencies, KSHV-specific immune responses are believed to be important in the control of KSHV replication. However, analysis of the roles of immune cells in viral pathogenesis has been difficult due to the lack of an adequate animal model. Recently, congenital OX40 deficiency, as determined by genome-wide exome sequencing, was shown to be associated with aggressive childhood KS in a patient, suggesting that disrupted OX40–OX40L interactions might be implicated in disease development. Here, we report that interaction of recombinant OX40 protein with OX40L expressed on endothelial cells severely impaired KSHV lytic replication. Furthermore, 4-1BB–4-1BBL interactions were also capable of efficiently inhibiting viral replication in B-cells and endothelial cells. To the best of our knowledge, this is the first direct evidence that ligation of tumour necrosis factor superfamily members and their cognate receptors is important for the control of viral lytic replication. These data are likely to pave the way for the development of KSHV-specific therapies for KS and MCD, in which viral lytic replication is a disease-determining factor.

  • Received:
  • Accepted:
  • Published Online:
© 2015 The Authors
Loading

Article metrics loading...

/content/journal/jgv/10.1099/jgv.0.000312
2015-12-01
2024-04-19
Loading full text...

Full text loading...

/deliver/fulltext/jgv/96/12/3635.html?itemId=/content/journal/jgv/10.1099/jgv.0.000312&mimeType=html&fmt=ahah

References

  1. Boshoff C., Schulz T. F., Kennedy M. M., Graham A. K., Fisher C., Thomas A., McGee J. O., Weiss R. A., O'Leary J. J. 1995; Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells. Nat Med 1:1274–1278 [View Article][PubMed]
     [Google Scholar]
  2. Brulois K., Toth Z., Wong L. Y., Feng P., Gao S. J., Ensser A., Jung J. U. 2014; Kaposi's sarcoma-associated herpesvirus K3 and K5 ubiquitin E3 ligases have stage-specific immune evasion roles during lytic replication. J Virol 88:9335–9349 [View Article][PubMed]
     [Google Scholar]
  3. Byun M., Abhyankar A., Lelarge V., Plancoulaine S., Palanduz A., Telhan L., Boisson B., Picard C., Dewell S., other authors. 2010; Whole-exome sequencing-based discovery of STIM1 deficiency in a child with fatal classic Kaposi sarcoma. J Exp Med 207:2307–2312 [View Article][PubMed]
     [Google Scholar]
  4. Byun M., Ma C. S., Akçay A., Pedergnana V., Palendira U., Myoung J., Avery D. T., Liu Y., Abhyankar A., other authors. 2013; Inherited human OX40 deficiency underlying classic Kaposi sarcoma of childhood. J Exp Med 210:1743–1759 [View Article][PubMed]
     [Google Scholar]
  5. Camcioglu Y., Picard C., Lacoste V., Dupuis S., Akçakaya N., Cokura H., Kaner G., Demirkesen C., Plancoulaine S., other authors. 2004; HHV-8-associated Kaposi sarcoma in a child with IFN(R1) deficiency. J Pediatr 144:519–523 [View Article][PubMed]
     [Google Scholar]
  6. Casper C., Nichols W. G., Huang M. L., Corey L., Wald A. 2004; Remission of HHV-8 and HIV-associated multicentric Castleman disease with ganciclovir treatment. Blood 103:1632–1634 [View Article][PubMed]
     [Google Scholar]
  7. Cesarman E., Chang Y., Moore P. S., Said J. W., Knowles D. M. 1995; Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med 332:1186–1191 [View Article][PubMed]
     [Google Scholar]
  8. Chang H. H., Ganem D. 2013; A unique herpesviral transcriptional program in KSHV-infected lymphatic endothelial cells leads to mTORC1 activation and rapamycin sensitivity. Cell Host Microbe 13:429–440 [View Article][PubMed]
     [Google Scholar]
  9. Chang Y., Cesarman K., Pessin M. S., Lee F., Culpepper J., Knowles D. M., Moore P. S. 1994; Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266:1865–1869 [View Article][PubMed]
     [Google Scholar]
  10. Ciufo D. M., Cannon J. S., Poole L. J., Wu F. Y., Murray P., Ambinder R. F., Hayward G. S. 2001; Spindle cell conversion by Kaposi's sarcoma-associated herpesvirus: formation of colonies and plaques with mixed lytic and latent gene expression in infected primary dermal microvascular endothelial cell cultures. J Virol 75:5614–5626 [View Article][PubMed]
     [Google Scholar]
  11. Croft M. 2009; The role of TNF superfamily members in T-cell function and diseases. Nat Rev Immunol 9:271–285 [View Article][PubMed]
     [Google Scholar]
  12. Croft M. 2010; Control of immunity by the TNFR-related molecule OX40 (CD134). Annu Rev Immunol 28:57–78 [View Article][PubMed]
     [Google Scholar]
  13. Croft M., Duan W., Choi H., Eun S. Y., Madireddi S., Mehta A. 2012; TNF superfamily in inflammatory disease: translating basic insights. Trends Immunol 33:144–152 [View Article][PubMed]
     [Google Scholar]
  14. Davidovici B., Karakis I., Bourboulia D., Ariad S., Zong J., Benharroch D., Dupin N., Weiss G., Hayward R. 2001; Seroepidemiology and molecular epidemiology of Kaposi's sarcoma-associated herpesvirus among Jewish population groups in Israel. J Natl Cancer Inst 93:194–202 [View Article][PubMed]
     [Google Scholar]
  15. Dupin N., Grandadam M., Calvez V., Gorin I., Aubin J. T., Havard S., Lamy F., Leibowitch M., Huraux J. M., other authors. 1995; Herpesvirus-like DNA sequences in patients with Mediterranean Kaposi's sarcoma. Lancet 345:761–762 [View Article][PubMed]
     [Google Scholar]
  16. Eckstein D. A., Penn M. L., Korin Y. D., Scripture-Adams D. D., Zack J. A., Kreisberg J. F., Roederer M., Sherman M. P., Chin P. S., Goldsmith M. A. 2001; HIV-1 actively replicates in naive CD4+ T cells residing within human lymphoid tissues. Immunity 15:671–682 [View Article][PubMed]
     [Google Scholar]
  17. Ensoli B., Stürzl M. 1998; Kaposi's sarcoma: a result of the interplay among inflammatory cytokines, angiogenic factors and viral agents. Cytokine Growth Factor Rev 9:63–83 [View Article][PubMed]
     [Google Scholar]
  18. Ensoli B., Sgadari C., Barillari G., Sirianni M. C., Stürzl M., Monini P. 2001; Biology of Kaposi's sarcoma. Eur J Cancer 37:1251–1269 [View Article][PubMed]
     [Google Scholar]
  19. Ganem D. 2007a; Kaposi's sarcoma-associated herpesvirus. In Fields Virology pp. 2847–2888 Edited by Knipe D. M., Howley P. M. Philadelphia, PA: Lippincott, Williams & Wilkins;
     [Google Scholar]
  20. Ganem D. 2007b; KSHV-induced oncogenesis. In Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis Edited by Arvin A., Campadelli-Fiume G., Mocarski E., Moore P. S., Roizman B., Whitley K., Yamanishi R. Cambridge: Cambridge University Press;
     [Google Scholar]
  21. Ganem D. 2010; KSHV and the pathogenesis of Kaposi sarcoma: listening to human biology and medicine. J Clin Invest 120:939–949 [View Article][PubMed]
     [Google Scholar]
  22. Gao S. J., Deng J. H., Zhou F. C. 2003; Productive lytic replication of a recombinant Kaposi's sarcoma-associated herpesvirus in efficient primary infection of primary human endothelial cells. J Virol 77:9738–9749 [View Article][PubMed]
     [Google Scholar]
  23. Goto E., Yamanaka Y., Ishikawa A., Aoki-Kawasumi M., Mito-Yoshida M., Ohmura-Hoshino M., Matsuki Y., Kajikawa M., Hirano H., Ishido S. 2010; Contribution of lysine 11-linked ubiquitination to MIR2-mediated major histocompatibility complex class I internalization. J Biol Chem 285:35311–35319 [View Article][PubMed]
     [Google Scholar]
  24. Imura A., Hori T., Imada K., Ishikawa T., Tanaka Y., Maeda M., Imamura S., Uchiyama T. 1996; The human OX40/gp34 system directly mediates adhesion of activated T cells to vascular endothelial cells. J Exp Med 183:2185–2195 [View Article][PubMed]
     [Google Scholar]
  25. Iscovich J., Boffetta P., Franceschi S., Azizi E., Sarid R. 2000; Classic Kaposi sarcoma: epidemiology and risk factors. Cancer 88:500–517[PubMed] [CrossRef]
     [Google Scholar]
  26. Ishido S., Wang C., Lee B. S., Cohen G. B., Jung J. U. 2000; Downregulation of major histocompatibility complex class I molecules by Kaposi's sarcoma-associated herpesvirus K3 and K5 proteins. J Virol 74:5300–5309 [View Article][PubMed]
     [Google Scholar]
  27. Kunitomi A., Hori T., Imura A., Uchiyama T. 2000; Vascular endothelial cells provide T cells with costimulatory signals via the OX40/gp34 system. J Leukoc Biol 68:111–118[PubMed]
     [Google Scholar]
  28. Li J., Yin Q., Wu H. 2013; Structural basis of signal transduction in the TNF receptor superfamily. Adv Immunol 119:135–153 [View Article][PubMed]
     [Google Scholar]
  29. Martin D. F., Kuppermann B. D., Wolitz R. A., Palestine A. G., Li H., Robinson C. A., Roche Ganciclovir Study Group. 1999; Oral ganciclovir for patients with cytomegalovirus retinitis treated with a ganciclovir implant. N Engl J Med 340:1063–1070 [View Article][PubMed]
     [Google Scholar]
  30. Moore P. S., Chang Y. 1995; Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and without HIV infection. N Engl J Med 332:1181–1185 [View Article][PubMed]
     [Google Scholar]
  31. Myoung J., Ganem D. 2011a; Active lytic infection of human primary tonsillar B cells by KSHV and its noncytolytic control by activated CD4+ T cells. J Clin Invest 121:1130–1140 [View Article][PubMed]
     [Google Scholar]
  32. Myoung J., Ganem D. 2011b; Generation of a doxycycline-inducible KSHV producer cell line of endothelial origin: maintenance of tight latency with efficient reactivation upon induction. J Virol Methods 174:12–21 [View Article][PubMed]
     [Google Scholar]
  33. Myoung J., Ganem D. 2011c; Infection of lymphoblastoid cell lines by Kaposi's sarcoma-associated herpesvirus: critical role of cell-associated virus. J Virol 85:9767–9777 [View Article][PubMed]
     [Google Scholar]
  34. Myoung J., Ganem D. 2011d; Infection of primary human tonsillar lymphoid cells by KSHV reveals frequent but abortive infection of T cells. Virology 413:1–11 [View Article][PubMed]
     [Google Scholar]
  35. Parravicini C., Chandran B., Corbellino M., Berti E., Paulli M., Moore P. S., Chang Y. 2000; Differential viral protein expression in Kaposi's sarcoma-associated herpesvirus-infected diseases: Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease. Am J Pathol 156:743–749 [View Article][PubMed]
     [Google Scholar]
  36. Picard C., Mellouli F., Duprez R., Chédeville G., Neven B., Fraitag S., Delaunay J., Le Deist F., Fischer A., other authors. 2006; Kaposi's sarcoma in a child with Wiskott-Aldrich syndrome. Eur J Pediatr 165:453–457 [View Article][PubMed]
     [Google Scholar]
  37. Polizzotto M. N., Uldrick T. S., Wang V., Aleman K., Wyvill K. M., Marshall V., Pittaluga S., O'Mahony D., Whitby D., other authors. 2013; Human and viral interleukin-6 and other cytokines in Kaposi sarcoma herpesvirus-associated multicentric Castleman disease. Blood 122:4189–4198 [View Article][PubMed]
     [Google Scholar]
  38. Sedy J., Bekiaris V., Ware C. F. 2014; Tumor necrosis factor superfamily in innate immunity and inflammation. Cold Spring Harb Perspect Biol 7:a016279[PubMed] [CrossRef]
     [Google Scholar]
  39. Seko Y., Takahashi N., Oshima H., Shimozato O., Akiba H., Takeda K., Kobata T., Yagita H., Okumura K., other authors. 2001; Expression of tumour necrosis factor (TNF) ligand superfamily co-stimulatory molecules CD30L, CD27L, OX40L, and 4-1BBL in murine hearts with acute myocarditis caused by Coxsackievirus B3. J Pathol 195:593–603 [View Article][PubMed]
     [Google Scholar]
  40. Serraino D., De Paoli A., Zucchetto A., Pennazza S., Bruzzone S., Spina M., De Paoli P., Rezza G., Dal Maso L., Suligoi B. 2010; The impact of Kaposi sarcoma and non-Hodgkin lymphoma on mortality of people with AIDS in the highly active antiretroviral therapies era. Cancer Epidemiol 34:257–261 [View Article][PubMed]
     [Google Scholar]
  41. Shiels M. S., Pfeiffer R. M., Gail M. H., Hall H. I., Li J., Chaturvedi A. K., Bhatia K., Uldrick T. S., Yarchoan R., other authors. 2011; Cancer burden in the HIV-infected population in the United States. J Natl Cancer Inst 103:753–762 [View Article][PubMed]
     [Google Scholar]
  42. Soulier J., Grollet L., Oksenhendler E., Cacoub P., Cazals-Hatem D., Babinet P., d'Agay M. F., Clauvel J. P., Raphael M., other authors. 1995; Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood 86:1276–1280[PubMed]
     [Google Scholar]
  43. Staskus K. A., Zhong W., Gebhard K., Herndier B., Wang H., Renne R., Beneke J., Pudney J., Anderson D. J., other authors. 1997; Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells. J Virol 71:715–719[PubMed]
     [Google Scholar]
  44. Summers deLuca L., Gommerman J. L. 2012; Fine-tuning of dendritic cell biology by the TNF superfamily. Nat Rev Immunol 12:339–351[PubMed]
     [Google Scholar]
  45. Uldrick T. S., Polizzotto M. N., Aleman K., O'Mahony D., Wyvill K. M., Wang V., Marshall V., Pittaluga S., Steinberg S. M., other authors. 2011; High-dose zidovudine plus valganciclovir for Kaposi sarcoma herpesvirus-associated multicentric Castleman disease: a pilot study of virus-activated cytotoxic therapy. Blood 117:6977–6986 [View Article][PubMed]
     [Google Scholar]
  46. Vieira J., Huang M. L., Koelle D. M., Corey L. 1997; Transmissible Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in saliva of men with a history of Kaposi's sarcoma. J Virol 71:7083–7087[PubMed]
     [Google Scholar]
  47. Vinay D. S., Kwon B. S. 1998; Role of 4-1BB in immune responses. Semin Immunol 10:481–489 [View Article][PubMed]
     [Google Scholar]
  48. Vinay D. S., Kwon B. S. 2009; TNF superfamily: costimulation and clinical applications. Cell Biol Int 33:453–465 [View Article][PubMed]
     [Google Scholar]
  49. Vinay D. S., Kwon B. S. 2011; 4-1BB signaling beyond T cells. Cell Mol Immunol 8:281–284 [View Article][PubMed]
     [Google Scholar]
  50. Weninger W., Partanen T. A., Breiteneder-Geleff S., Mayer C., Kowalski H., Mildner M., Pammer J., Stürzl M., Kerjaschki D., other authors. 1999; Expression of vascular endothelial growth factor receptor-3 and podoplanin suggests a lymphatic endothelial cell origin of Kaposi's sarcoma tumor cells. Lab Invest 79:243–251[PubMed]
     [Google Scholar]
  51. Yoo S. M., Ahn A. K., Seo T., Hong H. B., Chung M. A., Jung S. D., Cho H., Lee M. S. 2008; Centrifugal enhancement of Kaposi's sarcoma-associated virus infection of human endothelial cells in vitro. J Virol Methods 154:160–166 [View Article][PubMed]
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/jgv.0.000312
Loading
OX40 and 4-1BB downregulate Kaposi's sarcoma-associated herpesvirus replication in lymphatic endothelial cells, but 4-1BB and not OX40 inhibits viral replication in B-cells
J. Gen. Virol. 96, 3635 (2015); https://doi.org/10.1099/jgv.0.000312
/content/journal/jgv/10.1099/jgv.0.000312
/content/journal/jgv/10.1099/jgv.0.000312
Loading

Data & Media loading...

Supplements

Supplementary Data

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error